| http://www.w3.org/ns/prov#value | - Specific microRNAs released from prostate cancer cells in body fluids, such as blood or urine, can serve as novel biomarkers for diagnosis, prognosis, prediction, or monitoring of cancer patients.Some studies described an upregulation of miR-21, miR-200c, and miR-375 in prostate cancer tissue compared to nonmalignant prostate tissue [66, 95, 108, 109].
|
